Search

everythinglearnresearchcommunity

for

Search:↓

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Neutered ferrets often develop hyperadrenocorticism, with symptoms like hair loss and lethargy, and androstenedione is a key indicator for diagnosis.

MicroRNAs are crucial for skin development, regeneration, and disease treatment.

Hair shaft dysplasias are abnormal hair conditions that can be inherited or acquired and may signal other health issues, with limited treatment options available.

Data-driven methods can effectively identify existing drugs for new uses, especially in cancer, infections, and respiratory diseases.

Accurate diagnosis of progressive supranuclear palsy requires thorough neurological assessments and MRI.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

The document explains various skin conditions and their treatments.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Skin aging is a complex process influenced by various factors, leading to wrinkles and sagging, and should be considered a disease due to its health impacts.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Antioxidants can benefit skin health but should be used carefully to avoid negative effects.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Maintaining DNA health in stem cells is key to preventing aging and tissue breakdown.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Modern techniques have improved the understanding of keratin proteins, revealing their roles in various cells and potential in disease diagnosis.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.